Search Content | UT Health San Antonio MD Anderson Cancer Center

Search Result for ""

Research & Publications

Perioperative inhibition of B-adrenergic and COX2 signaling in a clinical trial in breast cancer patients improves tumor Ki-67 expression, serum cytokine levels, and PBMCs transcriptome

Research & Publications

Differential effects of EGFL6 on tumor versus wound angiogenesis

Research & Publications

Macrophage depletion through Colony Stimulating Factor 1 Receptor pathway blockade overcomes adaptive resistance to anti-VEGF therapy

Research & Publications

Immune cell profiling in cancer: molecular approaches to cell-specific identification

provider

David Haile, MD Hematology-Oncology, Stem Cell Transplantation

provider

Leyla Bojanini, MD Hematology-Oncology, Internal Medicine

provider

Gerardo Rosas, MD Hematology-Oncology

Research & Publications

Aphase1a/ 1bfirst-in-human, open-label, dose-escalation, safety, pharmacokinetic, and pharmacodynamic study of oral TP-0903, a potent inhibitor of AXL kinase, administered daily for 21 days to patients with advanced solid tumors.

Research & Publications

The Role of Genetics in sporadic GEP-NETs: A Comprehensive Review of the Literature

Story

UT Health San Antonio scientists uncover how some cancers outsmart immune system

FOXM1 protein identified as key driver in immunotherapy resistance, unlocking new therapeutic avenues For years, scientists have found the overexpression of a specific protein called FOXM1 in a wide range of cancers, including ovarian, breast and pediatric cancers. A recent study by scientists at The University of Texas Health Science Center at San Antonio […]